| Adding Maraviroc to Antiretroviral Therapy for Suboptimal CD4 T-Cell Recovery Despite Sustained Virologic Suppression (NCT00709111) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2009-01-01 |
| HIV and Kidney Function Study (NCT00905151) | Tufts Medical Center | 2009-01-01 |
| Effect of Raltegravir on Endothelial Function in HIV-Infected Patients (NCT00843713) | University of California, San Francisco | 2009-01-01 |
| ID and Testing Via Friendship Networks (NCT00841360) | University of North Carolina, Chapel Hill | 2009-01-01 |
| Prevention of Lipoatrophy in Patients Treated With Lopinavir/Ritonavir in Monotherapy Versus ZDV + 3TC + ABC (NCT00865475) | Fundacion SEIMC-GESIDA | 2008-12-01 |
| Switching Nevirapine Immediate Release( IR) Based Regimen to Nevirapine Extended Release (XR) Based Regimen in Human Immunodeficiency Virus One (HIV-1) Infected Patients (NCT00819052) | Boehringer Ingelheim | 2008-12-01 |
| Reducing HIV: Safer Sex Skill Building in Pregnant Drug Abusing Women (NCT00619320) | Virginia Commonwealth University | 2008-12-01 |
| Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat Recovery in Persons With Lipoatrophy (NCT00865007) | Fundacion SEIMC-GESIDA | 2008-12-01 |
| High-dose Chemotherapy With Transplantation of Gene-modified Haematopoietic Stem Cells for HIV-positive Patients With Malignant Diseases Indicating an HSCT (NCT00858793) | Universitätsklinikum Hamburg-Eppendorf | 2008-11-28 |
| A School-Based HIV/STD Prevention Program to Reduce Risky Sexual Behaviors Among Adolescents in Liberia (NCT00698321) | Pacific Institute for Research and Evaluation | 2008-11-01 |
| Safety and Immunogenicity of TBC-M4, a MVA HIV Vaccine Alone or in a Prime-Boost Regimen With ADVAX DNA HIV Vaccine (NCT00902824) | International AIDS Vaccine Initiative | 2008-11-01 |
| Effectiveness of Communication Technology in Disseminating HIV Prevention Training to Non-governmental Organizations (NCT00698529) | Medical College of Wisconsin | 2008-11-01 |
| Empowerment Intervention for Young Women - Phase I (NCT00891358) | University of North Carolina, Chapel Hill | 2008-11-01 |
| Pharmacokinetics of Emtricitabine/Tenofovir/Efavirenz in HIV-infected Patients With Tuberculosis (NCT00474435) | African Poverty Related Infection Oriented Research Initiative | 2008-11-01 |
| Influenza Vaccination at a Reduced Dose Using Mesotherapy in HIV/AIDS Patients at the Hadassah AIDS Center, Jerusalem (NCT00758212) | Hadassah Medical Organization | 2008-11-01 |
| Impact of Different Contraceptives on the Immune System of HIV Infected Women in Zambia (NCT00807625) | University of Alabama at Birmingham | 2008-11-01 |
| Safety of and Immune Response to Two HIV Vaccines: SAAVI DNA-C2 Boosted With SAAVIMVA-C, in HIV-Negative Adults (NCT00574600) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-11-01 |
| Hepatitis B and HIV Co-Infection in Patients in Uganda (NCT00782158) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-10-27 |
| CCR5 Inhibitor Treatment Intensification on CD4+ T-cell Recovery (NCT00925756) | University of California, San Diego | 2008-10-20 |
| Smoking Cessation Using Motivational Therapy and Varenicline (NCT00701896) | Philip Diaz | 2008-10-03 |
| Immune Responses to Pneumococcal Vaccination Among HIV-infected Subjects (NCT00706550) | US Department of Veterans Affairs | 2008-10-01 |
| Spatial Epidemiology of HIV Infection (NCT01377272) | National Taiwan University Hospital | 2008-10-01 |
| Behavioral Intervention to Reduce Sexual and Injection Risks Among Female Sex Workers Who Also Inject Drugs in Mexico (NCT00840658) | Steffanie Strathdee | 2008-10-01 |
| Comparison of Liquid Kaletra and Low Dose Kaletra Tablets (NCT00762320) | Phoenix Children's Hospital | 2008-10-01 |
| Effectiveness of Antiretroviral Therapy During Acute HIV Infection (NCT00705926) | Massachusetts General Hospital | 2008-10-01 |
| Effectiveness of a Cell Phone-Based Program for Abstinence and HIV Risk Prevention (NCT00601237) | University of Colorado, Denver | 2008-10-01 |
| Safety and Pharmacokinetic Study of Fixed Dose Combination of Zidovudine, Lamivudine, and Nevirapine in HIV-Infected Children in Thailand (NCT00672412) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-10-01 |
| IMARA, Adapting SiHLE for Detained African American Adolescent Females (NCT00746369) | Emory University | 2008-10-01 |
| Safety Study of TXA127 to Elevate CD4+ T-Lymphocyte Counts in HIV-Infected Patients on Stable HAART Therapy (NCT00757250) | US Biotest, Inc. | 2008-09-01 |
| Immunogenicity and Safety Trial of the HIV-1 Tat Vaccine (NCT00751595) | Barbara Ensoli, MD | 2008-09-01 |
| HIV-1 Specific Immune Responses in Thai Individuals With HIV Dementia (NCT00777426) | SEARCH Research Foundation | 2008-09-01 |
| PMS Assessing the Long-term Efficacy and Safety of Nevirapine Therapy (Combined With Other ARV Drugs) in HIV-1 Positive Patients in Daily Clinical Practice. (NCT00736502) | Boehringer Ingelheim | 2008-09-01 |
| Trial of Cognitive Behavioral Therapy to Reduce Antiretroviral Therapy Side Effects (NCT00696839) | Duquesne University | 2008-09-01 |
| Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/r (NCT00756730) | Community Research Initiative of New England | 2008-09-01 |
| Raltegravir Therapy for Women With HIV and Fat Accumulation (NCT00656175) | University of California, Los Angeles | 2008-09-01 |
| Comparing Raltegravir Genital Tract Distribution in HIV-infected Men and Women (NCT00745368) | University of Rochester | 2008-09-01 |
| Safety Study of Lopinavir/Ritonavir With Raltegravir in HIV-infected Patients (NCT00752037) | Saint Michael's Medical Center | 2008-09-01 |
| Pilot Study on the Effect of Adding Raltegravir +/- a Second Drug on HIV Levels in the Gut (NCT00884793) | University of California, San Francisco | 2008-09-01 |
| Intervention for (Those) Recently Informed of Seropositive Status (IRISS) (NCT00720733) | University of California, San Francisco | 2008-09-01 |
| Cognitive and Psychosocial Benefits of MISC Training for Ugandan Children (NCT00889395) | Makerere University | 2008-09-01 |
| Effects of 2 Initial Standard Antiretroviral Combinations Therapies on Lipid Metabolism (NCT00759070) | Juan A. Arnaiz | 2008-09-01 |
| Healthy Activities for Prize Incentives (NCT00717444) | UConn Health | 2008-09-01 |
| Therapy Targeting Depression and HIV Treatment Adherence (The TRIAD Study) (NCT00951028) | Massachusetts General Hospital | 2008-09-01 |
| Pharmacokinetic Study of Two Generic Co-formulations of Lopinavir/Ritonavir for HIV Infected Children (SURF) (NCT00665951) | Radboud University Medical Center | 2008-09-01 |
| Raltegravir + Lopinavir/Ritonavir Versus Efavirenz + Tenofovir + Emtricitabine in Treatment Naive Patients (NCT00752856) | University of California, San Diego | 2008-08-26 |
| Observational Study of HIV Infected Women Previously Enrolled in Other Microbicide Trials (NCT00514098) | Microbicide Trials Network | 2008-08-25 |
| Adult Sexual Risk Behavior Among Women With a History of Childhood Sexual Abuse (NCT00653575) | Syracuse University | 2008-08-01 |
| Video-based Counseling & Rapid HIV Testing for Teens (NCT00836550) | North Bronx Healthcare Network | 2008-08-01 |
| Clinical Trial Assessing Once Daily Raltegravir Administration (800 mg QD) in HIV-1-Infected Patients Receiving Unboosted Atazanavir (400 mg QD)- Based Antiretroviral Therapy (NCT00718536) | Germans Trias i Pujol Hospital | 2008-08-01 |
| Genetic Predictors of Raltegravir Penetration Into Cerebrospinal Fluid (NCT00729924) | Vanderbilt University | 2008-08-01 |
| Raltegravir Added to Stable HAART in HIV-1 Infected Subjects With Viral Suppression and Low CD4 Recovery (NCT00562510) | Pedro Cahn | 2008-08-01 |
| Retention and Duration of Activity of SPL7013 (VivaGel®) After Vaginal Dosing. (NCT00740584) | Starpharma Pty Ltd | 2008-08-01 |
| A Network Intervention for Reducing Sexual Risk for HIV With African American Men Who Have Sex With Men (AA MSM) (NCT00691041) | Centers for Disease Control and Prevention | 2008-08-01 |
| An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials (NCT03337906) | HIV Vaccine Trials Network | 2008-07-11 |
| Impact of HIV Infection on Latent Tuberculosis (TB) Among Patients With HIV-TB Co-infection (NCT00692809) | Ministry of Science and Technology, India | 2008-07-01 |
| Safety Study of the HemoModulator System for the Treatment of Patients With Human Immunodeficiency Virus (HIV) (NCT00858923) | Energex Systems, Inc. | 2008-07-01 |
| Prevalence and Determinants of Chronic Obstructive Pulmonary Disease (COPD) in HIV+ Patients (NCT00904384) | Cimera | 2008-07-01 |
| Evaluation of 4 New Simplified Antiretroviral Treatments in Naive HIV-1 Infected Patients in Africa (ANRS 12115 DAYANA) (NCT00573001) | French National Agency for Research on AIDS and Viral Hepatitis | 2008-07-01 |
| Cohort Study of HIV-1 Incidence Among Clients of the Thai Red Cross AIDS Research Center, Bangkok, Thailand (NCT00713531) | SEARCH Research Foundation | 2008-07-01 |
| Maternal/Infant Peripartum NVP, Versus Infant Only Peripartum NVP, or Maternal LPV/r in Addition to Standard ZDV Prophylaxis for the Prevention of Perinatal (PMTCT) HIV in Thailand (NCT00409591) | Institut de Recherche pour le Developpement | 2008-07-01 |
| Effects of Mixed Exercise Regime and L-Carnitine Supplementation in HIV Patients on HAART (NCT00572429) | University of California, Davis | 2008-07-01 |
| Examination of B Cell Responses in Human Blood (NCT00806845) | Regenerative Medicine Network | 2008-07-01 |
| Directly Administered Antiretroviral Therapy (DAART) Among HIV-1infected Injecting Drug Users (IDUs) in Chennai, India (NCT00709007) | Johns Hopkins University | 2008-07-01 |
| Cerebrospinal Fluid (CSF) Raltegravir Substudy (NCT00718029) | University of California, San Diego | 2008-07-01 |
| Relationship Between HIV-1 Subtype and ARV Response (NCT00585793) | University of Wisconsin, Madison | 2008-07-01 |
| Depression and ART Adherence in HIV+ Latinos (NCT01411839) | University of Washington | 2008-07-01 |
| Project ICARE: Intervening for Community Awareness, Respect, & Empowerment (NCT00712088) | Centers for Disease Control and Prevention | 2008-07-01 |
| Proyecto SOL: A Risk Reduction Intervention for Hispanic Men Who Have Sex With Men (MSM) (NCT00690976) | Centers for Disease Control and Prevention | 2008-07-01 |
| Measurement of Adherence to ART in HIV-Infected Children in Uganda (The CHARTA Study) (NCT00868257) | Massachusetts General Hospital | 2008-07-01 |
| Phase I Study of HIV Adenoviral Vector Vaccine in Healthy Subjects Using Needle or Biojector Injection (NCT00709605) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-06-25 |
| Response to Standard HIV Treatment in Bamako, Mali (NCT00703404) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-06-18 |
| Pilot Study to Determine the Safety and Efficacy of Gardasil Against the Human Papilloma Virus (HPV) in HIV-infected Men (NCT00666107) | Southern California Institute for Research and Education | 2008-06-01 |
| TMC278-TiDP6-C215: A Clinical Trial in Treatment Naive HIV-subjects Patients Comparing TMC278 to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NCT00543725) | Tibotec Pharmaceuticals, Ireland | 2008-06-01 |
| Efficacy and Safety of Switching From Retrovir to Tenofovir or Abacavir in HIV-infected Patients (NCT00647244) | Aarhus University Hospital | 2008-06-01 |
| Pharmacokinetics of Generic Lopinavir/Ritonavir in Pregnant Women (NCT00621166) | The HIV Netherlands Australia Thailand Research Collaboration | 2008-06-01 |
| A Study to Evaluate the Effect of Famotidine and Omeprazole on MK0518 (Raltegravir) Pharmacokinetics in Human Immunodeficiency Virus (HIV)-Infected Patients (0518-054) (NCT01000818) | Merck Sharp & Dohme LLC | 2008-06-01 |
| A Phase I Study of Modified Vaccinia Virus Ankara (MVA-B) in Healthy Volunteers at Low Risk of HIV Infection (NCT00679497) | Juan A. Arnaiz | 2008-06-01 |
| The Prevalence of HIV Drug Resistance and Transmission Risk in Opioid Agonist Treatment (NCT00857350) | Yale University | 2008-06-01 |
| Cotrimoxazole Prophylaxis Cessation Study Among Stabilized HIV-Infected Adult Patients on HAART in Entebbe, Uganda (NCT00674921) | MRC/UVRI and LSHTM Uganda Research Unit | 2008-06-01 |
| Effectiveness of Armodafinil for Treating Fatigue in Adults With HIV/AIDS (NCT00737204) | New York State Psychiatric Institute | 2008-06-01 |
| HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy in Spain (NCT00685191) | Germans Trias i Pujol Hospital | 2008-06-01 |
| Pilot Study of Text Message Reminders to Improve HIV Medication Adherence in Botswana (NCT01001741) | University of Pennsylvania | 2008-06-01 |
| Effectiveness of Integrating Prenatal Care in Reducing HIV/STDs Among Young Pregnant Women (NCT00628771) | Yale University | 2008-06-01 |
| Kaletra-isentress Treatment Evaluation (NCT00700115) | Emory University | 2008-06-01 |
| Evaluation of the Efficacy of Hydroxychloroquine in Decreasing Immune Activation in Asymptomatic HIV-infected Patients (NCT01067417) | Medical Research Council | 2008-06-01 |
| Anatomic and Visual Function Assessments on Asymptomatic HIV-positive Patients (NCT00871078) | Federal University of São Paulo | 2008-06-01 |
| A Study of Invirase (Saquinavir)/Ritonavir in HIV-Infected Infants and Children. (NCT00623597) | Hoffmann-La Roche | 2008-06-01 |
| Surveillance Cohort Long-term Toxicity Antiretrovirals in HIV-infected Patients Enrolled in TPV Cohort (NCT00805857) | Boehringer Ingelheim | 2008-06-01 |
| Qualitative Assessment of Implementing Routine Rapid HIV Testing (NCT00680862) | US Department of Veterans Affairs | 2008-06-01 |
| Adherence and Acceptability to and Blood Levels of Tenofovir Gel and Tablets in HIV Uninfected Women (NCT00592124) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-06-01 |
| Raltegravir as Early Therapy in African-Americans Living With HIV Study (NCT00667433) | David A Wohl, MD | 2008-06-01 |
| Evaluating Post-test HIV Counseling Videos for Teens (NCT00851539) | North Bronx Healthcare Network | 2008-06-01 |
| Culturally-Tailored HIV Risk Reduction for African-American MSM (NCT00691561) | Medical College of Wisconsin | 2008-06-01 |
| No Excuses/Sin Buscar Excusas Intervention to Reduce Latino Men's HIV Risks (NCT00690690) | Centers for Disease Control and Prevention | 2008-06-01 |
| Sleep Quality and Presence of Sleep Disordered Breathing (NCT00692965) | University of Florida | 2008-06-01 |
| Phase I Safety Study of a Recombinant MVA HIV Multiantigen Vaccine in HIV-infected Subjects (NCT00623259) | Bavarian Nordic | 2008-05-01 |
| HIV Counseling and Testing and Linkage to Care in Uganda (NCT00648232) | University of California, Los Angeles | 2008-05-01 |
| A Behavioral Intervention to Reduce Sexual Risk Among African-American Men Who Have Sex With Men (NCT00691496) | Centers for Disease Control and Prevention | 2008-05-01 |
| Kaletra and Viread in Antiretroviral Naïve Patients (NCT00679926) | Oklahoma State University Center for Health Sciences | 2008-05-01 |
| Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition Within HIV-1 Discordant Couples (NCT00557245) | University of Washington | 2008-05-01 |